Public

Slide 1

Fragility Fractures

Public Resources

Screening to prevent fragility fractures

What are fragility fractures?

  • Fragility fractures are breaks at the hip, spine, wrist and other areas after a fall that wouldn’t normally cause a break if bones were strong
  • They are due to underlying weakened bone structure, also called low bone mineral density. Fragility fractures can lead to chronic pain, disability, hospitalization, need for long-term care and earlier death
  • Screening should start with a risk assessment tool and may be followed by a bone mineral density (BMD) X-ray

A new guideline from the Canadian Task Force on Preventive Health Care on screening to prevent fragility fractures recommends “risk assessment-first” screening for women 65 and older.

Should you be screened to help reduce the risk of fragility fractures?

  • Females aged 65+ may be able to avoid fracture with screening and medication
  • Screening is not recommended for females under 65 or males of any age
  • Use the online Fragility Fracture Decision Aid to calculate your risk level. If your risk is low, medication won’t really change this.
  • The decision aid can help you talk to your health care provider. It calculates your individual risk and the potential benefits and harms of medication.
  • Women should know their risk and be supported as they decide about BMD testing and preventive treatment.

Find out more here.

Illustration of women over 65 years old.

Use the Fragility Fracture Decision Aid for shared decision-making to calculate your risk.

Who is the guideline for?

  • Adults aged 40+ who live independently in the community
  • It is not for people already taking prescription medication to prevent fragility fractures

“This new information will surely help family physicians and patients have meaningful discussions and forego unnecessary tests. Why do a test if your risk is low and you’re not interested in taking preventive medication?”

– Marie-France, a patient in her 50s living in Quebec who has had many BMD tests

Learn more about screening here.

Public Tools and Resources

What is screening?

Colour PDF

Web Article

View Article

About Task Force

About Us

Colour PDF

Screenshot of guideline development process figure.

Our Methodology

Colour PDF

Task Force History

Colour PDF

Guideline Development Process

Colour PDF

Org Chart

Colour PDF

Our Members

Visit Members Page